Data as of 3:33pm ET
| +0.0088 / +1.29%|
The 1 analysts offering 12-month price forecasts for Boston Therapeutics Inc have a median target of 1.95, with a high estimate of 1.95 and a low estimate of 1.95. The median estimate represents a +182.61% increase from the last price of 0.69.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.